BRIEF-Clearmind Medicine Enters Development Agreement For Intranasal Formulation Of Proprietary Nonhallucinogenic Neuroplastogen MEAI

Polyrizon Ltd. -1.50% Post
Clearmind Medicine Inc. -28.57% Post

Polyrizon Ltd.

PLRZ

11.14

11.14

-1.50%

0.00% Post

Clearmind Medicine Inc.

CMND

0.65

0.65

-28.57%

-0.77% Post

- Clearmind Medicine Inc CMND.O:

  • CLEARMIND MEDICINE ENTERS INTO DEVELOPMENT AGREEMENT TO ADVANCE INTRANASAL FORMULATION FOR ITS PROPRIETARY NON-HALLUCINOGENIC NEUROPLASTOGEN MEAI

Source text: ID:nGNX8L1NC0

Further company coverage: CMND.O